Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Non-alcoholic Fatty Liver Disease: From Steatosis to Cirrhosis

Date

Authors

Farrell, Geoffrey

Larter, Claire

Publisher

W B Saunders Co

Abstract

Nonalcoholic steatohepatitis (NASH), the lynchpin between steatosis and cirrhosis in the spectrum of nonalcoholic fatty liver disorders (NAFLD), was barely recognized in 1981. NAFLD is now present in 17% to 33% of Americans, has a worldwide distribution,

Keywords

Keywords: alpha tocopherol; ascorbic acid; betaine; cytokine; glitazone derivative; metformin; pentoxifylline; peroxisome proliferator activated receptor alpha agonist; peroxisome proliferator activated receptor gamma agonist; pioglitazone; placebo; rosiglitazone;

URI

http://hdl.handle.net/1885/57331

Collections

ANU Research Publications

Source

Hepatology

Type

Journal article

DOI

10.1002/hep.20973

Restricted until

2037-12-31

Downloads

File

Description

01_Farrell_Non-alcoholic_Fatty_Liver_2006.pdf (4.14 MB)